Sold by: Next Move Strategy Consulting
Deployed on AWS
The global Base Editing Market was valued at USD 313.5 million in 2024 and is projected to grow to USD 741.1 million by 2030, reflecting a compound annual growth rate (CAGR) of 15.4%. The increasing prevalence of cancer is fueling the demand for base editing technologies, as researchers seek advanced techniques to create targeted cancer treatments through DNA modification.
Overview
Factors such as the rising incidence of cancer, increased adoption of base editing technologies, and the expansion of healthcare sectors are driving market growth. However, the high upfront costs associated with developing and deploying these technologies present significant challenges to market expansion. On the other hand, the integration of artificial intelligence (AI) offers promising future opportunities by enabling the analysis of large genomic datasets.
Furthermore, key players in the market, including Editas Medicine Inc., Intellia Therapeutics Inc., and CRISPR Therapeutics AG, are undertaking various initiatives, such as product launches and partnerships, to enhance their market presence. These efforts are expected to accelerate the development of targeted treatments. Companies are also focusing on creating products that improve accessibility to gene editing platforms for clinical trials.
The rapidly developing field of base editing also offers new possibilities for agriculture, enhancing crop yields and quality, as well as improving traits such as disease resistance, drought tolerance, and nutrition. This has contributed significantly to market growth, especially in some of the least developed countries where it already accounts for more than 25%. The growing demand for crop improvement in agriculture is driving the wider adoption of gene editing technologies.
Download FREE Sample: https://www.nextmsc.com/base-editing-market-hc2980/request-sample
The expansion of the healthcare sector has significantly increased demand for advanced gene-editing technologies like base editing, particularly for developing targeted therapies and making specific DNA adjustments to cure genetic disorders and other diseases. According to the World Bank Group, health expenditure per capita rose to USD 1,265 in 2021 from USD 1,179 in 2020, reflecting a 6.8% growth in just one year. This surge in healthcare spending underscores the growing need for innovative gene-editing solutions, such as base editing, to tackle complex medical challenges and fuel market growth.
Inquire before purchase: https://www.nextmsc.com/base-editing-market-hc2980/inquire-before-buying
Despite these opportunities, high development and deployment costs, along with the time-consuming nature of research and development, continue to hinder market growth. AI integration in base editing is expected to create significant growth opportunities by analyzing large genomic datasets to identify optimal target sequences and predict the outcomes of genetic modifications. This reduces research time and costs. The adoption of AI streamlines the development of innovative solutions for both medicine and agriculture, making processes faster and more efficient.
Access full report - https://www.nextmsc.com/report/base-editing-market-hc2980
Currently, North America dominates the base editing market and is expected to maintain this lead throughout the forecast period. This is primarily due to the rising number of cancer cases in the region, which drives demand for advanced treatment options and facilitates the development of targeted therapies for specific cancer types.
On the other hand, the Asia-Pacific region is considered the fastest-growing market for base editing, driven by the rapid expansion of the healthcare sector. The region is seeing substantial investment in advanced medical and biotechnological innovations, improving healthcare outcomes and increasing patient demand.
The base editing industry is composed of several key players, including Editas Medicine Inc., Intellia Therapeutics Inc., CRISPR Therapeutics AG, Beam Therapeutics Inc., Verve Therapeutics, Inc., Revvity Inc., Mammoth Biosciences, Lonza Group AG, Integrated DNA Technologies Inc., ProQR Therapeutics NV, Bio Palette Co., Ltd, GenScript Biotech Corporation, ElevateBio LLC, Maravai LifeSciences, DH Life Sciences, LLC, and others. These companies are employing various strategies, such as product launches and collaborations, to maintain their dominance in the market.
About Next Move Strategy Consulting:
Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider committed to delivering high-quality market research reports. We assist multinational companies in gaining a competitive edge and expanding their industry presence by capturing a larger market share. Our research methodology combines primary research, secondary research, data mining, and data analytics to deliver reliable insights.
Over a decade, we have served over 1,000 global customers, including 90% of Fortune 500 companies. Our analysts constantly monitor high-growth markets and uncover hidden opportunities in various sectors. We offer top-quality syndicated and custom research reports across ten different industry verticals, catering to your unique business needs. Our industry-standard delivery solutions, from pre-consultation to after-sales services, ensure an exceptional client experience and support informed strategic decision-making.
Contact Us:
Next Move Strategy Consulting
E-Mail: info@nextmsc.com
Direct: +1-217-650-7991
Website: https://www.nextmsc.com/
Details
Delivery method
Deployed on AWS
New
Introducing multi-product solutions
You can now purchase comprehensive solutions tailored to use cases and industries.
Features and programs
Financing for AWS Marketplace purchases
AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
Pricing
This product is available free of charge. Free subscriptions have no end date and may be canceled any time.
Additional AWS infrastructure costs may apply. Use the AWS Pricing Calculator to estimate your infrastructure costs.
Dimensions summary
This listing has one pricing dimension: Product Access (Units). It grants subscribers access to the market research report at no cost. There are no tiers, usage add-ons, or size-based options to compare. You gain access through this single free dimension. After access is confirmed, the report is delivered as a digital file by email or download link, typically within 24 to 48 hours.
Top-of-mind questions for buyers
One unit grants you access to this single market research report. You receive the report as a digital file in PDF, Excel, or Word format. Access covers the report content only. Custom analysis on specific market aspects is not included and carries a separate cost.
No. All sales are final. The vendor does not accept cancellations, returns, or refunds once a report is sold and delivered. Because reports are digital and contain sensitive data, no refund applies after dispatch. Contact the vendor's support team with any questions before you obtain access.
Digital reports are available for download within 24 to 48 hours of payment confirmation. Delivery may take longer if the report requires customization. Reports arrive by email or as a download link. Printed copies, if requested, are couriered within three working days of payment receipt.
www.nextmsc.com+1
Helpful?
Vendor refund policy
All sales are final; no refunds or returns are accepted. Our reports include sensitive, researched data from various sources, including industry experts and paid services. We ensure confidentiality and offer customization at an additional cost. Please review our terms before purchase. For inquiries, contact customer service.
Legal
Vendor terms and conditions
Upon subscribing to this product, you must acknowledge and agree to the terms and conditions outlined in the vendor's End User License Agreement (EULA) .
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Delivery details
AWS Data Exchange (ADX)
AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.
Additional details
You will receive access to the following data sets.
Data set name | Type | Historical revisions | Future revisions | Sensitive information | Data dictionaries | Data samples |
|---|---|---|---|---|---|---|
NMSC_MarketResearch | All historical revisions | All future revisions | Not included | Not included |
Resources
Vendor resources
Similar products
60-minute live analyst briefing focused on the Base Editing Market (2026–2035), helping biotechnology, genomics, and healthcare strategy leaders optimize AWS cloud infrastructure, AI workloads, and genomic analytics roadmaps.
60-minute live analyst briefing focused on the Base Editing Market (2026–2035), helping biotech, pharma, and genomic service leaders optimize AWS-based genomics infrastructure, AI-driven R&D scaling, and strategic investment planning.
Get file-based market sizing, segmentation, competitive benchmarking, and company profiles for the global Gene Editing Market, including a projected USD 17.79 billion value by 2030 and a 16.9% CAGR from 2025-2030
Gain comprehensive insights into the global Custom Clothing Market with historical analysis and forecasts through 2030. The report provides in-depth analysis of market size, growth trends, competitive landscape, regional outlook, and future opportunities across the custom apparel industry.